Supernus Pharmaceuticals
Utility Patents

Last updated:

List of all Supernus Pharmaceuticals patents 6 in total

Status Patent
Grant
Utility: Use of higher doses of modified release huperzine formulations External link
Filling date: 8 Sep 2025 Issue date: 7 Jun 2022
Grant
Utility: Method of treatment of attention deficit/hyperactivity disorder (ADHD) External link
Filling date: 8 Sep 2025 Issue date: 10 May 2022
Grant
Utility: Modified release preparations containing oxcarbazepine and derivatives thereof External link
Filling date: 8 Sep 2025 Issue date: 9 Nov 2021
Grant
Utility: Methods of producing molindone and its salts External link
Filling date: 8 Sep 2025 Issue date: 14 Sep 2021
Grant
Utility: Stabilized formulations of CNS compounds External link
Filling date: 8 Sep 2025 Issue date: 3 Aug 2021
Grant
Utility: Methods of producing molindone and its salts External link
Filling date: 8 Sep 2025 Issue date: 9 Jun 2020

Showing 1 to 6 of 6 patents.